ZSH-2117
ZSH-2117 is an NEDD4-recruiting EGFR PROTAC degrader. ZSH-2117 shows an IC50 of 13 nM against EGFRL858R/T790M/C797S, induces EGFR proteasome-dependent degradation, inhibits the downstream signaling pathways of EGFR, including the phosphorylation of AKT and ERK, suppresses cancer cell proliferation, and exhibits in vivo anti-tumor activity. ZSH-2117 can be used in research related to non-small cell lung cancer.
(Pink: EGFR ligand (HY-175162); Blue: NEDD4 ligand (HY-175159); Black: linker).
For research use only. We do not sell to patients.
- Formula: C36H39BrClN8O2P
- Molecular Weight:762.08
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
EGFRL858R/T790M/C797S 13 nM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BaF3 | DC50 |
45 nM
|
Half-maximal degradation concentration of EGFRL858R/T790M/C797S in Ba/F3-EGFRL858R/T790M/C797S cells assessed by Western blot analysis after 8 h of treatment.
Half-maximal degradation concentration of EGFRL858R/T790M/C797S in Ba/F3-EGFRL858R/T790M/C797S cells assessed by Western blot analysis after 8 h of treatment.
|
40506832 |
| NCI-H1975 | DC50 |
149 nM
|
Half-maximal degradation concentration of FLAG-EGFRL858R/T790M/C797S in H1975-FLAG-EGFRL858R/T790M/C797S cells assessed by Western blot analysis after 8 h of treatment.
Half-maximal degradation concentration of FLAG-EGFRL858R/T790M/C797S in H1975-FLAG-EGFRL858R/T790M/C797S cells assessed by Western blot analysis after 8 h of treatment.
|
40506832 |
| BaF3 | IC50 |
13 nM
|
Half-maximal inhibitory concentration for proliferation inhibition in Ba/F3-EGFRL858R/T790M/C797S cells assessed via cell viability measurement.
Half-maximal inhibitory concentration for proliferation inhibition in Ba/F3-EGFRL858R/T790M/C797S cells assessed via cell viability measurement.
|
40506832 |
ZSH-2117 (0.001-100 μM) potently inhibits the proliferation of Ba/F3-EGFRL858R/T790M/C797S cells, with an IC50 of 13 nM[1].
ZSH-2117 (0.2 μM; 8 h) potently degrades EGFRL858R/T790M/C797S in Ba/F3-EGFRL858R/T790M/C797S cells[1].
ZSH-2117 (25-200 nM; 8 h) potently induces concentration-dependent degradation of EGFRL858R/T790M/C797S in Ba/F3-EGFRL858R/T790M/C797S cells, with a DC50 of 45 nM and a maximum degradation rate of 96%[1].
ZSH-2117 (100 nM; 10 h)-mediated degradation of EGFRL858R/T790M/C797S in Ba/F3-EGFRL858R/T790M/C797S cells relies on the proteasome, the activity of E1 ligase, and requires binding to EGFRL858R/T790M/C797S[1].
ZSH-2117 (0.5 μM; 3 h) competes with probe AZ9-1 for binding to the E3 ligase NEDD4 in Ba/F3-EGFRL858R/T790M/C797S cells[1].
ZSH-2117 (0.1-3 μM; 8 h) potently induces concentration-dependent degradation of FLAG-EGFRL858R/T790M/C797S in H1975-FLAG-EGFRL858R/T790M/C797S cells, with a DC50 of 149 nM and a maximum degradation rate of 94%[1].
The NEDD4-dependent degradation of FLAG-EGFRL858R/T790M/C797S mediated by ZSH-2117 (0.2 μM; 8 h) occurs in H1975-FLAG-EGFRL858R/T790M/C797S cells[1].
ZSH-2117 (0.2 μM; 8 h)-mediated degradation of FLAG-EGFRL858R/T790M/C797S and formation of the EGFR-NEDD4 ternary complex in H1975-FLAG-EGFRL858R/T790M/C797S cells depend on the C1286 residue of NEDD4[1].
ZSH-2117 (0.5 μM; 4 h) covalently binds to the cysteine residue C1286 on the surface of NEDD4 in H1975 cells expressing HA-NEDD4-EGFRL858R/T790M/C797S[1].
ZSH-2117 (25-500 nM; 8 h) inhibits the downstream signaling pathways of EGFR (phosphorylation of AKT and ERK) in Ba/F3-EGFRL858R/T790M/C797S cells in a concentration-dependent manner in vitro, and simultaneously induces the degradation of EGFRL858R/T790M/C797S[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Ba/F3-EGFRL858R/T790M/C797S
-
Concentration:0.2 μM
-
Incubation Time:8 h
-
Result:Exhibited the highest degradation activity for EGFRL858R/T790M/C797S among tested analogs.
Reduced protein levels to a significantly lower percentage of control than DMSO, ZSH-1136, ZSH-2155, ZSH-2158, and ZSH-3005.
-
Cell Line:Ba/F3-EGFRL858R/T790M/C797S
-
Concentration:25, 50, 100, 200 nM
-
Incubation Time:8 h
-
Result:Induced concentration-dependent degradation of EGFRL858R/T790M/C797S.
Achieved a half-maximal degradation concentration (DC50) of 45 nM.
Reached a maximum degradation (Dmax) of 96%.
-
Cell Line:Ba/F3-EGFRL858R/T790M/C797S
-
Concentration:100 nM
-
Incubation Time:10 h
-
Result:Attenuated EGFRL858R/T790M/C797S degradation.
Showed no effect on EGFRL858R/T790M/C797S degradation.
Blocked EGFRL858R/T790M/C797S degradation.
-
Cell Line:H1975-FLAG-EGFRL858R/T790M/C797S
-
Concentration:0.1, 0.3, 1, 3 μM
-
Incubation Time:8 h
-
Result:Induced concentration-dependent degradation of FLAG-EGFRL858R/T790M/C797S.
Achieved a half-maximal degradation concentration (DC50) of 149 nM.
Reached a maximum degradation (Dmax) of 94%.
-
Cell Line:H1975-FLAG-EGFRL858R/T790M/C797S
-
Concentration:0.2 μM
-
Incubation Time:8 h
-
Result:Completely eliminated ZSH-2117-induced degradation of FLAG-EGFRL858R/T790M/C797S with knockdown of NEDD4.
Showed significant degradation of FLAG-EGFRL858R/T790M/C797S in shScramble control cells.
Completely blocked ZSH-2117-induced degradation of FLAG-EGFRL858R/T790M/C797S with NEDD4 C1286A mutant.
Abolished the interaction between NEDD4 and FLAG-EGFRL858R/T790M/C797S with NEDD4 C1286A mutant.
-
Cell Line:Ba/F3-EGFRL858R/T790M/C797S
-
Concentration:25, 50, 100, 200, 500 nM
-
Incubation Time:8 h
-
Result:Induced concentration-dependent reductions in p-EGFR, p-AKT(S473), and p-ERK levels.
Corresponded reduced EGFRL858R/T790M/C797S protein levels with decreased downstream signaling levels.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NOD-SCID mice[1]
-
Dosage:2.5 mg/kg
-
Administration:i.p.; administered on days 0, 3, 5 and 7
-
Result:Achieved a tumor growth inhibition (TGI) rate of 65%.
Significantly reduced tumor volume and tumor weight relative to vehicle control.
Degraded EGFRL858R/T790M/C797S protein in tumor tissues.
Had minimal impact on mouse body weight.
Chemical Information
-
Molecular Weight 762.08
-
Formula C36H39BrClN8O2P
-
SMILES
O=C(N1CCN(C2CCN(C3=CC=C(NC4=NC=C(Cl)C(NC5=CC=CC=C5P(C)(C)=O)=N4)C=C3Br)CC2)CC1)C6N=C6C7=CC=CC=C7
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)